EZH2 and posterior cortical atrophy: GSK‐J4 is a potent H3K27me3/me2 demethylase, and H3K27me3 levels were substantially reduced by treatment with GSK‐J4 (1 μM) in PCa cells of the control group or EZH2 overexpressing group (Figure 2G,H).